Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
This article was originally published in The Tan Sheet
Executive Summary
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction